Joint Formulary & PAD

Minocycline - Acne

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
NFD1
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Minocycline
Indication :
Acne
Group Name :
Keywords :
NHS England Low Value Medicines, do not prescribe, LVM, antibiotic, antibacterial, tetracycline,
Brand Names Include :
Acnamino, Minocin MR, Aknemin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Minocycline is used to treat.

Committee Recommendations (2)

At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.

If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.

The Surrey & North West Sussex Area Prescribing Committee (APC) does not recommend minocycline as a treatment option for acne and a BLACK traffic light status is recommended. (NB: Not recommended for use in any health setting across Surrey and NW Sussex health economy)

See policy statement below for more information and key references.